Skip to main content
Premium Trial:

Request an Annual Quote

American Cancer Society Layoffs

The American Cancer Society has eliminated 1,000 positions across the US, the Cancer Letter reports.

According to the Atlanta Journal-Constitution, the ACS is anticipating a $200 million shortfall in revenue due to the coronavirus pandemic. Because of this decline in fundraising revenue, the Cancer Letter notes that the nonprofit is cutting its overall budget by about 30 percent.

The AJC adds that the ACS has laid off 150 employees in Atlanta, where the nonprofit is based, and a total of 1,000 employees across the US. The layoffs, it adds, were done in phases and affected employees working in information management, finance, marketing, communications, fundraising, and research. 

"There was no way to get where we needed to be for the time being without, unfortunately, making the decision to cut jobs," CEO Gary Reedy tells the AJC. "We're hoping and praying that we don't have to do more."

Executives have also taken pay cuts of between 10 percent and 20 percent, ABC News reports. It adds, though, that an ACS spokesperson cautions that if current financial trends continue, it may have to make additional cuts, including to research.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.